Biomagnetics Diagnostics Corp. engages in the provision of medical and biotechnology devices. The company is headquartered in Orangevale, California. The company went IPO on 2002-04-09. The Company’s diagnostics system focuses on real-time testing for the actual presence of the virus or toxin or disease itself and not for antibodies produced by the body's immune system which may take anywhere from weeks to months to appear. The Company’s products include High Throughput Screening - Magnetic Testing Platform (HTS-MTP) and Integrity Optical Biosensor (IOBS). Its HTS-MTP is designed to detect both qualitative chemical identification of the elements present in a substance and quantitative number of specific elements in a substance results from a single test. The firm triggered optical biosensor that is based on protein-receptor binding that brings two or more optically tagged receptors into close proximity using planar optical waveguides, thereby triggering fluorescence changes identified almost instantly by tiny on-board detectors.
Follow-Up Questions
Quelle est la performance du prix de l'action BMGP ?
Le prix actuel de BMGP est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Biomagnetics Diagnostics Corp ?
Biomagnetics Diagnostics Corp appartient à l'industrie Health Care et le secteur est Health Care
Quelle est la capitalisation boursière de Biomagnetics Diagnostics Corp ?
La capitalisation boursière actuelle de Biomagnetics Diagnostics Corp est de $0
